Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT06916520
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
300
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
Percutaneous Coronary Intervention (PCI)
ACTIVE_NOT_RECRUITING
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9
Enrollment(s)
6
Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor
ACTIVE_NOT_RECRUITING
NCT04494425
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
866
Enrollment(s)
293
Study location(s)
INTERVENTIONAL (PHASE3)
Advanced or Metastatic Breast Cancer
RECRUITING
NCT07217938
Novel Treatment of Radiation Associated Dysphagia With Statins
48
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Radiation-associated Dysphagia
Head &Amp; Neck Cancer
ACTIVE_NOT_RECRUITING
NCT04294628
Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer
62
Enrollment(s)
6
Study location(s)
INTERVENTIONAL (PHASE1)
Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm
COMPLETED
NCT03523585
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
608
Enrollment(s)
227
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
ACTIVE_NOT_RECRUITING
NCT03950076
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
948
Enrollment(s)
152
Study location(s)
INTERVENTIONAL (PHASE4)
Intracranial Hemorrhages
Atrial Fibrillation
11
12
13
14
15